Credicorp Ltd.
BAPCredicorp Ltd.'s price has outrun its earnings. +65.8% in a year against EPS +26.0% — the market is paying now for delivery later.
The sharpest disagreement: the price moved +65.8% in a year while annual EPS moved +26.0% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is in a confirmed uptrend (69 weeks in) while the P/BV sits at the 100th percentile of its own 5-year range. Underneath, the last four quarters read improving — profit +16.6% year on year, with the the net margin at 33.2%. What settles it: whether earnings grow into a price that has already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Credicorp Ltd. trades at $392, in a confirmed uptrend and 69 weeks into that stage. That is +20.4% against its own 200-day average. It sits at 94% of a 52-week range of $248 to $401. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 9 straight weeks.
Today the stock is in a confirmed uptrend — week 69 of stage 2. At $392 it trades +20.4% versus its 200-day average and sits at 94% of its 52-week range ($248–$401).
Against the market, two honest reads. Cumulative: over the last 10.1 years the stock moved +151% while the S&P 500 moved +263% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 9 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation For a bank we price the book, not the earnings: P/BV is what the market pays for each $1 of the bank's net worth. A bank below 1× book is priced below the value of what it owns, net of what it owes.
Credicorp Ltd. trades at 2.7× P/BV, about the priciest it has ever traded. Its long-run median P/BV is 0.4×, measured across 5.1 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/BV of 2.7× is about the priciest it has ever traded, against a long-run median of 0.4× measured over 5.1 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
🚨 Why the multiple sits where it does: over the past year book value grew while the price moved +65.8% — the price ran ahead of the book, pushing the multiple up its own range.
The price move, decomposed: over 5y, of the +30.8%/yr price move, ~+9.8%/yr came from book-value growth and ~+21.0 pp from the multiple (expanding). The split is the honest approximate (price return minus book-value growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the book-value line underneath it, not the multiple.
Stage: Consistent Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Credicorp Ltd. reads as consistent on its fundamental arc. Consistent — revenue, profit and EPS growth have stayed positive through the window, with ROE at 18.1% and holding. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: steady curves with healthy returns are the compounding setup — the risk is the price, not the business.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +7.5% | +15.4% | — | — |
| Profit | +26.0% | +14.2% | — | — |
| EPS | +26.0% | +14.3% | — | — |
| Stock price | +65.8% | +36.6% | +30.8% | +9.4% |
4-Factor Sector Score
61.2/100 — rank 1 of 18 in Banks - Regional · 62% evidence confidence
Credicorp Ltd. scores 61.2 out of 100 against the 18 companies it is compared with in Banks - Regional, ranking 1. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 25.5 + 13.7 + 5.7 + 16.3 = 61.2. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if ROA rolls over or gross NPA rises while sector-relative strength deteriorates.
Revenue For a bank, revenue is everything the franchise earns — interest on the loan book plus fees from its businesses.
Credicorp Ltd. reported $6.4 B of income in the Mar 26 quarter, +26.4% year on year. That is the 12th straight quarter of year-on-year growth. Over 4 years it has compounded at 16.2% a year. The last full year, FY25, came in at $23.8 B. The last four reported quarters add to $23.0 B.
FY25 revenue came in at $23.8 B (+7.5% on the year), capping 4 years at 16.2% compound. The latest quarter (Mar 26) printed $6.4 B, +26.4% year on year — the 12th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +23.5% growth against the decade's 16.2% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +23.6% over the last 4 quarters against +18.6%/yr over the last 8 — accelerating; TTM profit +24.9% vs +20.4%/yr — accelerating.
Net margin Net margin — what the bank keeps of every $100 of revenue after every cost, provision and tax. With big fee businesses in the mix, it is the cleanest margin we can read for this bank.
Credicorp Ltd.'s net margin is 33.2% in the Mar 26 quarter, −2.8 percentage points against the same quarter a year ago. Across 5 fiscal years the net margin has ranged 24.6% to 30.7%. The current quarter is running above every full year in that window.
The latest quarter's net margin is 33.2%, −2.8 pp against the same quarter a year ago. Across 5 fiscal years the net margin has ranged 24.6%–30.7%.
Why: the numbers show the net margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Credicorp Ltd. earned $2.1 B of net profit in the Mar 26 quarter, +16.6% year on year. It is the 7th consecutive quarter of growth. Full-year FY25 profit was $7.1 B. The 4-year compound rate is 17.9%. That is 33.2% of the quarter's revenue. The same quarter a year earlier earned $1.8 B.
Mar 26 profit was $2.1 B, +16.6% year on year — the 7th consecutive quarter of growth. On the full year, FY25 printed $7.1 B (+26.0%), and the 4-year compound rate is 17.9%.
Why profit moved: revenue contributed +26.4% and the margin −2.8 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit +26.5% vs revenue +23.5%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra dollar of revenue drops more to the bottom line.
Asset quality — the ladder Gross NPA is the slice of the loan book where repayments have stopped. Net NPA is what remains after the money already set aside against those loans. Falling is healing; rising is damage arriving.
Loan-book quality history is not available for Credicorp Ltd., so this section names the gap rather than estimating a ratio. No gross or net non-performing-asset series is filed in a form this page can read, and none is inferred from the profit line. The income, margin and return sections above carry the evidence this business does report.
We do not hold quarterly loan-book quality numbers for this bank, so this section states that plainly rather than working around it.
Why: loan-book quality is the engine room of a bank, and its drivers — slippages, recoveries, provisioning — sit below what we hold for this name; the sections around it carry the reads we can stand behind.
The loan book We read the loan book through revenue — when the book and the businesses grow, revenue grows with them. It is a rough proxy, and we say so: rate moves and fee swings can shift it a few points in any one year.
Credicorp Ltd.'s revenue grew +7.5% in FY25 to $23.8 B, so the book is growing. The latest quarter ran +26.4% year on year. The net margin on that income is 33.2%, −2.8 percentage points against a year ago. Interest income is a proxy for the book; rate moves can shift it a few points in any one year.
FY25 revenue was $23.8 B, +7.5% on the year, and the latest quarter ran +26.4% year on year. The net margin on that revenue is 33.2% this quarter (−2.8 pp YoY) — growth with a narrowing margin on it.
The synthesis: a lender compounds when the book grows while the margin holds and the loan book stays clean — with quarterly loan-quality numbers missing here, revenue growth and margin are the two we watch.
Returns on equity and assets Two numbers rate a bank: ROE — what it earns on shareholder money — and ROA — what it earns on everything it deploys. ROE above ~13–15% earns its keep; below that, growth builds book slowly.
Credicorp Ltd. earns a return on equity of 18% in FY25. Its trough over the ladder below was 14% in FY21. On the asset side every $100 of the balance sheet earned about $2.77, which is the return before leverage is applied.
FY25 ROE came in at 18%, recovered from a FY21 trough of 14%. On assets, the latest reading is about 2.77% — every $100 the bank deploys earns roughly $2.77 a year. That clears the bar a bank must beat for its book value to compound.
Why ROE moved: profit compounded 17.9% a year over 4 years while the equity base grew more slowly — earnings recovering faster than book value builds is what lifts ROE off a trough.
Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.
Credicorp Ltd. has 3 quarters of declared dividends on file — too few for a trailing-twelve-month figure. The most recent declaration was $50.00 for Dec 25.
Credicorp Ltd. has declared a dividend in 3 of the last 12 reported quarters, most recently $50.00 for Dec 25. That is fewer than four quarters, so no trailing-twelve-month total is shown rather than one built from a partial year.
Debt
For a bank, borrowings are raw material, not a warning sign — solvency is read through the returns and the loan book. A manufacturer’s debt is a claim against its profits, so the debt-to-equity lens that works everywhere else misleads on a lender and is not applied here.
A manufacturer’s debt is a claim against its profits; a bank’s borrowings are its inventory — money taken in to be lent out. The debt lens that works everywhere else misleads here, so this page does not apply it. The solvency questions for a bank — is the loan book sound, is the equity earning — are read through the loan-book and returns sections above.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
No ownership or positioning reading is held for Credicorp Ltd., so this section names the gap rather than filling it. At typical trading volumes those positions would take about 3.0 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
We hold no ownership or positioning reading for this stock, so this section says that plainly.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Credicorp Ltd.: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre. The Z-score was built for manufacturers and is not applied to banks and lenders, so solvency here is read from the capital and asset-quality lines instead.
The safety line in one sentence: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Credicorp Ltd.this pageBAP | 61.2/100Mixed-positive evidence62% evidence | BREAKING OUT | 25.5/35 Income 23.6% · PAT 25.2% 55% evidence | 13.7/25 ROA — · ROE 5.5% · GNPA — 34% evidence | 5.7/20 P/BV 2.35× · P/BV÷ROE 0.43 70% evidence | 16.3/20 RS sector 9.8% · RS bench 12.4% · 1Y 57.4%4 of 12 weeks ahead 100% evidence |
| Exact sum: 25.5 + 13.7 + 5.7 + 16.3 = 61.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Pinnacle Financial Partners, Inc.PNFP | 51.9/100Thin evidence · provisional51% evidence | TURNING | 21.6/35 Income 21.7% · PAT 48.7% 29% evidence | 11.0/25 ROA — · ROE 2.6% · GNPA — 26% evidence | 7.2/20 P/BV 1.06× · P/BV÷ROE 0.41 70% evidence | 12.1/20 RS sector 0.3% · RS bench 3% · 1Y 21.3%2 of 12 weeks ahead 100% evidence |
| Exact sum: 21.6 + 11 + 7.2 + 12.1 = 51.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 3Nu Holdings Ltd.NU | 44.0/100Mixed-negative evidence62% evidence | ASLEEP | 26.6/35 Income 34.5% · PAT 48.2% 55% evidence | 13.2/25 ROA — · ROE 8.2% · GNPA — 34% evidence | 3.0/20 P/BV 5.55× · P/BV÷ROE 0.68 70% evidence | 1.2/20 RS sector -16.9% · RS bench -14.7% · 1Y 16.5%0 of 12 weeks ahead 100% evidence |
| Exact sum: 26.6 + 13.2 + 3 + 1.2 = 44 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -16.9% and the one-year return is 16.5%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 4NatWest Group plcNWG | 55.4/100Thin evidence · provisional44% evidence | TURNING | 17.7/35 Income — · PAT — 3% evidence | 13.2/25 ROA — · ROE 3.9% · GNPA — 34% evidence | 8.6/20 P/BV 1.21× · P/BV÷ROE 0.31 70% evidence | 15.9/20 RS sector 3.8% · RS bench 6.5% · 1Y 34.9%5 of 12 weeks ahead 100% evidence |
| Exact sum: 17.7 + 13.2 + 8.6 + 15.9 = 55.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 5M&T Bank CorporationMTB | 53.4/100Thin evidence · provisional46% evidence | TURNING | 17.9/35 Income — · PAT — 10% evidence | 11.5/25 ROA — · ROE 2.9% · GNPA — 34% evidence | 6.1/20 P/BV 1.25× · P/BV÷ROE 0.43 70% evidence | 17.9/20 RS sector 5.1% · RS bench 7.7% · 1Y 35.2%5 of 12 weeks ahead 100% evidence |
| Exact sum: 17.9 + 11.5 + 6.1 + 17.9 = 53.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 6U.S. BancorpUSB | 52.6/100Thin evidence · provisional46% evidence | BREAKING OUT | 17.6/35 Income — · PAT — 10% evidence | 12.8/25 ROA — · ROE 3.4% · GNPA — 34% evidence | 6.7/20 P/BV 1.39× · P/BV÷ROE 0.41 70% evidence | 15.5/20 RS sector 4.8% · RS bench 7.4% · 1Y 43.2%4 of 12 weeks ahead 100% evidence |
| Exact sum: 17.6 + 12.8 + 6.7 + 15.5 = 52.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 7Lloyds Banking Group plcLYG | 52.2/100Thin evidence · provisional46% evidence | TURNING | 17.2/35 Income — · PAT — 10% evidence | 12.4/25 ROA — · ROE 3.3% · GNPA — 34% evidence | 6.6/20 P/BV 1.36× · P/BV÷ROE 0.41 70% evidence | 16.0/20 RS sector 5.3% · RS bench 7.9% · 1Y 42.3%3 of 12 weeks ahead 100% evidence |
| Exact sum: 17.2 + 12.4 + 6.6 + 16 = 52.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 8The PNC Financial Services Group, Inc.PNC | 51.2/100Thin evidence · provisional46% evidence | BREAKING OUT | 17.9/35 Income — · PAT — 10% evidence | 12.8/25 ROA — · ROE 3.4% · GNPA — 34% evidence | 5.3/20 P/BV 1.54× · P/BV÷ROE 0.45 70% evidence | 15.2/20 RS sector 3.9% · RS bench 6.5% · 1Y 33.9%6 of 12 weeks ahead 100% evidence |
| Exact sum: 17.9 + 12.8 + 5.3 + 15.2 = 51.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 9First Citizens BancShares, Inc.FCNCA | 48.6/100Thin evidence · provisional46% evidence | TURNING | 17.9/35 Income — · PAT — 10% evidence | 12.0/25 ROA — · ROE 3% · GNPA — 34% evidence | 8.0/20 P/BV 1.1× · P/BV÷ROE 0.37 70% evidence | 10.7/20 RS sector -0.4% · RS bench 2.3% · 1Y 23.2%4 of 12 weeks ahead 100% evidence |
| Exact sum: 17.9 + 12 + 8 + 10.7 = 48.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 10Citizens Financial Group, Inc.CFG | 47.7/100Thin evidence · provisional46% evidence | TURNING | 18.3/35 Income — · PAT — 10% evidence | 9.6/25 ROA — · ROE 2.3% · GNPA — 34% evidence | 4.4/20 P/BV 1.13× · P/BV÷ROE 0.49 70% evidence | 15.4/20 RS sector 8% · RS bench 10.6% · 1Y 55.8%6 of 12 weeks ahead 100% evidence |
| Exact sum: 18.3 + 9.6 + 4.4 + 15.4 = 47.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 11Fifth Third BancorpFITB | 47.0/100Thin evidence · provisional46% evidence | BREAKING OUT | 16.4/35 Income — · PAT — 10% evidence | 11.5/25 ROA — · ROE 2.9% · GNPA — 34% evidence | 3.8/20 P/BV 1.48× · P/BV÷ROE 0.51 70% evidence | 15.3/20 RS sector 4.4% · RS bench 7% · 1Y 38.7%7 of 12 weeks ahead 100% evidence |
| Exact sum: 16.4 + 11.5 + 3.8 + 15.3 = 47 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 12Regions Financial CorporationRF | 45.6/100Thin evidence · provisional46% evidence | BREAKING OUT | 16.6/35 Income — · PAT — 10% evidence | 12.0/25 ROA — · ROE 3% · GNPA — 34% evidence | 5.1/20 P/BV 1.37× · P/BV÷ROE 0.46 70% evidence | 11.9/20 RS sector 1.6% · RS bench 4.3% · 1Y 28.2%5 of 12 weeks ahead 100% evidence |
| Exact sum: 16.6 + 12 + 5.1 + 11.9 = 45.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 13East West Bancorp, Inc.EWBC | 44.4/100Thin evidence · provisional46% evidence | BREAKING OUT | 17.2/35 Income — · PAT — 10% evidence | 13.4/25 ROA — · ROE 4.2% · GNPA — 34% evidence | 4.9/20 P/BV 1.91× · P/BV÷ROE 0.46 70% evidence | 8.9/20 RS sector 1.9% · RS bench 4.6% · 1Y 34.6%6 of 12 weeks ahead 100% evidence |
| Exact sum: 17.2 + 13.4 + 4.9 + 8.9 = 44.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 14Deutsche Bank AktiengesellschaftDB | 42.0/100Thin evidence · provisional46% evidence | TURNING | 17.2/35 Income — · PAT — 10% evidence | 10.0/25 ROA — · ROE 2.4% · GNPA — 34% evidence | 8.4/20 P/BV 0.83× · P/BV÷ROE 0.35 70% evidence | 6.4/20 RS sector -6.3% · RS bench -3.7% · 1Y 3.3%5 of 12 weeks ahead 100% evidence |
| Exact sum: 17.2 + 10 + 8.4 + 6.4 = 42 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 15Webster Financial CorporationWBS | 40.6/100Thin evidence · provisional46% evidence | TURNING | 15.9/35 Income — · PAT — 10% evidence | 11.0/25 ROA — · ROE 2.7% · GNPA — 34% evidence | 4.9/20 P/BV 1.31× · P/BV÷ROE 0.48 70% evidence | 8.8/20 RS sector 2.1% · RS bench 4.7% · 1Y 39.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 15.9 + 11 + 4.9 + 8.8 = 40.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 16Huntington Bancshares IncorporatedHBAN | 39.1/100Thin evidence · provisional46% evidence | TURNING | 16.7/35 Income — · PAT — 10% evidence | 11.0/25 ROA — · ROE 2.7% · GNPA — 34% evidence | 7.5/20 P/BV 1.1× · P/BV÷ROE 0.41 70% evidence | 3.9/20 RS sector -9.1% · RS bench -6.7% · 1Y 9.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 16.7 + 11 + 7.5 + 3.9 = 39.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 17Truist Financial CorporationTFC | 39.0/100Thin evidence · provisional46% evidence | TURNING | 18.3/35 Income — · PAT — 10% evidence | 9.2/25 ROA — · ROE 2.4% · GNPA — 34% evidence | 7.7/20 P/BV 0.97× · P/BV÷ROE 0.4 70% evidence | 3.8/20 RS sector -4.5% · RS bench -2.1% · 1Y 22.3%1 of 12 weeks ahead 100% evidence |
| Exact sum: 18.3 + 9.2 + 7.7 + 3.8 = 39 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 18KeyCorpKEY | 36.0/100Thin evidence · provisional46% evidence | TURNING | 16.9/35 Income — · PAT — 10% evidence | 9.7/25 ROA — · ROE 2.6% · GNPA — 34% evidence | 4.7/20 P/BV 1.26× · P/BV÷ROE 0.49 70% evidence | 4.7/20 RS sector -1.2% · RS bench 1.3% · 1Y 31.2%1 of 12 weeks ahead 100% evidence |
| Exact sum: 16.9 + 9.7 + 4.7 + 4.7 = 36 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Credicorp Ltd.'s stock price today?
Credicorp Ltd. trades at $392, +65.8% over the past year. The company is valued at $31.0 B. The stock sits at 94% of its 52-week range of $248–$401, +20.4% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 69 weeks in. — as of 5 August 2026.
What were Credicorp Ltd.'s latest quarterly results?
Credicorp Ltd. reported total income of $6.4 B and net profit of $2.1 B for the Mar 26 quarter. Income rose 26.4% and profit rose 16.6% year on year. Earnings per share were $25.90. The net margin was 33.2%, 2.8 pp lower than a year earlier. — as of 5 August 2026.
What is Credicorp Ltd.'s revenue?
Credicorp Ltd. reported revenue of $6.4 B in the Mar 26 quarter, +26.4% year on year. For the full FY25 fiscal year, revenue was $23.8 B (+7.5%). Over the last 4 years revenue compounded at 16.2% a year. — as of 5 August 2026.
What is Credicorp Ltd.'s profit?
Credicorp Ltd. earned $2.1 B of net profit in the Mar 26 quarter, +16.6% year on year — the 7th straight quarter of growth. Full-year FY25 profit was $7.1 B. The net margin ran 33.2% in the latest quarter. — as of 5 August 2026.
What is Credicorp Ltd.'s market cap?
Credicorp Ltd.'s market capitalisation is $31.0 B at a stock price of $392. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
What is Credicorp Ltd.'s P/BV ratio?
Credicorp Ltd. trades at a P/BV of 2.7×, at the 100th percentile of its own 5-year range, against a long-run median of 0.4×. This is a comparison with the stock's own history, not a value call — as of 5 August 2026.
Does Credicorp Ltd. pay a dividend?
Yes — Credicorp Ltd. declared $50.00 per share for Dec 25 (3 quarters on file, too few for a trailing-twelve-month total). The latest quarter is up 25.3% on the same quarter a year earlier. — as of 5 August 2026.
What is Credicorp Ltd.'s dividend per share?
Credicorp Ltd.'s most recently declared dividend is $50.00 per share for Dec 25. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 5 August 2026.
Is Credicorp Ltd. overvalued?
On its own history, Credicorp Ltd. looks expensive against its own history: its P/BV of 2.7× sits at the 100th percentile of its 5-year range (long-run median 0.4×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 5 August 2026.
Is Credicorp Ltd. growing?
Yes — Credicorp Ltd. is growing: latest-quarter revenue +26.4% year on year, profit +16.6%, and the the net margin −2.8 pp at 33.2%. The 4-year compound rates are 16.2% (revenue) and 17.9% (profit). The earnings engine currently reads: improving — as of 5 August 2026.
How is Credicorp Ltd. performing?
Credicorp Ltd. is in a confirmed uptrend, 69 weeks in. Its latest quarter's income rose 26.4% and profit rose 16.6% year on year. Against the S&P 500 it has been ahead on a trailing-13-week view for 9 weeks. This describes what the data did, not a rating. — as of 5 August 2026.
What stage is Credicorp Ltd. in?
Consistent — revenue, profit and EPS growth have stayed positive through the window, with ROE at 18.1% and holding. The read comes from the last 12 quarters of growth (revenue growth +23.6% latest, profit growth +24.9% latest, eps growth +25.1% latest) plus the ROE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 5 August 2026.
Is Credicorp Ltd. in an uptrend?
Yes — the price is in a confirmed uptrend (week 69 of stage 2), trading +20.4% versus its 200-day average and at 94% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.
Is Credicorp Ltd. beating the market?
On recent form, yes — Credicorp Ltd. has been ahead of the S&P 500 on a trailing-13-week view for 9 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.1 years the stock moved +151% against the S&P 500's +263% — behind the index over the full window. — as of 5 August 2026.
Will Credicorp Ltd.'s stock price go up?
This page publishes no price forecast for Credicorp Ltd. What it measures instead: the stock price is $392, the price is in a confirmed uptrend 69 weeks in. Its P/BV of 2.7× sits at the 100th percentile of its own 5-year range. — as of 5 August 2026.
Is Credicorp Ltd.'s loan book healthy?
We do not hold quarterly loan-book quality numbers for Credicorp Ltd., so this page says that plainly. The cleanest available reads are revenue growth (+7.5% in FY25) and the net margin on it (33.2%) — as of 5 August 2026.
Where is Credicorp Ltd. in its business cycle?
Credicorp Ltd.'s FY25 net margin was 29.7%, against a 5-year band of 24.6%–30.7%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 33.2%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the Credicorp Ltd. story?
The sharpest disagreement: the price moved +65.8% in a year while annual EPS moved +26.0% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is Credicorp Ltd. a stock worth studying right now?
This is not investment advice. The machine read: Credicorp Ltd.'s price has outrun its earnings. +65.8% in a year against EPS +26.0% — the market is paying now for delivery later. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.